CAM
MRNA icon

Close Asset Management’s Moderna MRNA Stock Holding History

Close Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75
Closed -$2K – 283
2025
Q4 		$2K Hold
75
– – ﹤0.01% 260
2025
Q3 		$2K Sell
75
-100
-57% -$2.79K ﹤0.01% 254
2025
Q2 		$5K Sell
175
-500
-74% -$13.2K ﹤0.01% 230
2025
Q1 		$19K Hold
675
– – ﹤0.01% 192
2024
Q4 		$28K Hold
675
– – ﹤0.01% 176
2024
Q3 		$45K Hold
675
– – ﹤0.01% 166
2024
Q2 		$80K Buy
675
+75
+13% +$9.49K ﹤0.01% 146
2024
Q1 		$64K Buy
600
+250
+71% +$25.2K ﹤0.01% 151
2023
Q4 		$35K Hold
350
– – ﹤0.01% 162
2023
Q3 		$36K Buy
350
+80
+30% +$8.92K ﹤0.01% 153
2023
Q2 		$33K Buy
270
+250
+1,250% +$33.4K ﹤0.01% 173
2023
Q1 		$3K Buy
+20
New +$3.3K ﹤0.01% 220
2021
Q4 		– Sell
-36
Closed -$14K – 211
2021
Q3 		$14K Buy
+36
New +$13.3K ﹤0.01% 178

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Close Asset Management's MRNA Position: Q1 2026 in Review

Close Asset Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 75 shares — an estimated $2K sold.

Close Asset Management first reported a position in MRNA in Q3 2021 and held it in 13 quarters. The position peaked at $80K in Q2 2024. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Close Asset Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Close Asset Management sold 75 Moderna shares in Q1 2026, an estimated $2K.
  • Close Asset Management first reported a position in Moderna in Q3 2021 and held it in 13 quarters.
  • Close Asset Management's Moderna position peaked at $80K in Q2 2024.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.